Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today and set a price ...

The stock's fall snapped a four-day winning streak.

Big pharma’s pushing for PBS funding, and it’s kickstarting a shift to healthier snacks, smaller portions, and more ...

But over time, your decision to buy or sell a company’s stock should be based on what you believe will happen in the future.

As the first earnings season of 2025 unfolds, investors are likely analyzing financial reports to refine their portfolio strategies.

Some of the market’s biggest winners start off as the smallest players. While trillion-dollar tech giants like the ...

Viking Therapeutics (NASDAQ: VKTX) shares exploded higher after the clinical-stage drugmaker announced successful results ...

BofA analyst sees Block poised for growth in 2025 with strong GPV growth, strategic partnerships, and potential S&P 500 inclusion.

Tapestry, which owns Coach, Kate Spade and Stuart Weitzman brands, reported second-quarter revenue of $2.2 billion, beating analyst estimates of $2.11 billion, according to Benzinga Pro. The company ...

Eli Lilly and Co (NYSE:LLY) stock is trading higher after the company released better-than-expected fourth-quarter earnings ...

Eli Lilly stock rose after the drugmaker posted quarterly earnings that beat Wall Street expectations, and issued upbeat 2025 guidance. Fourth-quarter adjusted earnings came in at $5.32 a share, above ...